Naida Cemalovic, MD
Obstetrics & Gynecology · Astoria, NYNPI 1073672218
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.1% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $166 and has fallen 81.3% since, to $31 in 2025. That places this record below the midpoint for obstetrics & gynecology clinicians in NY, where the typical reported total is $302.
Across 15 payments — averaging $22.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scynexis, Inc.$66
- Therapeuticsmd, Inc.$66
- AbbVie$49
- Millicent US Inc$36
- Boston Scientific$31
- AMAG Pharmaceuticals, Inc.$23
- plus $60 from 3 others
What the payments were for
- Food & beverage$30793%
- Education$237%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scynexis, Inc. | 3 | $66 |
| Therapeuticsmd, Inc. | 3 | $66 |
| AbbVie | 2 | $49 |
| Millicent US Inc | 2 | $36 |
| Boston Scientific | 1 | $31 |
| AMAG Pharmaceuticals, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $23 |
| Coopersurgical, Inc. | 1 | $19 |
| Lupin Inc. | 1 | $18 |
How this compares
$330 in reported general payments places this provider in the 50th percentile of 2,673 obstetrics & gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 46 | $2,971 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 46 | $700 |
| ValacyclovirValacyclovir Hcl | 21 | $162 |
| Alendronate Sodium | 22 | $146 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 20 | $131 |
| Fluconazole | 30 | $128 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Astoria
- Mary PolanNew York$862K
- Steven GoldsteinNew York$551K
- Veronica LernerNew York$368K
- Lisa EngNew York$219K
- Theodore GoldmanEast Northport$213K
- Miriam CremerBrooklyn$196K
- Rachel MaschNew York$187K
- Amy PollackNew York$184K
- Jian Qun HuangNew York$160K
- Carolyn WesthoffNew York$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.